COVID-19 : Patient, Diagnosis-Specific Resources

April 1, 2020

COVID-19 & Substance Abuse

COVID-19 & Substance Abuse DEA Issues Guidance for Prescribing Buprenorphine During COVID-19 Emergency The U.S. Drug Enforcement Administration (DEA) issued guidance to DEA-registered physicians prov

March 26, 2020

COVID-19 & Palliative Care

March 23, 2020

COVID-19 & Sickle Cell Patients

March 23, 2020

COVID-19 & Pediatric Patients

March 23, 2020

COVID-19 & Geriatric Patients